Growth Metrics

Larimar Therapeutics (LRMR) Times Interest Earned (2016 - 2020)

Historic Times Interest Earned for Larimar Therapeutics (LRMR) over the last 7 years, with Q1 2020 value amounting to -$11.84.

  • Larimar Therapeutics' Times Interest Earned rose 5542.21% to -$11.84 in Q1 2020 from the same period last year, while for Mar 2020 it was -$22.94, marking a year-over-year increase of 2419.55%. This contributed to the annual value of -$25.85 for FY2019, which is 1972.38% up from last year.
  • Latest data reveals that Larimar Therapeutics reported Times Interest Earned of -$11.84 as of Q1 2020, which was up 5542.21% from -$20.11 recorded in Q4 2019.
  • Larimar Therapeutics' Times Interest Earned's 5-year high stood at -$11.84 during Q1 2020, with a 5-year trough of -$1669.8 in Q4 2017.
  • Its 5-year average for Times Interest Earned is -$188.47, with a median of -$34.28 in 2018.
  • Per our database at Business Quant, Larimar Therapeutics' Times Interest Earned tumbled by 144621.24% in 2017 and then skyrocketed by 9823.68% in 2018.
  • Over the past 5 years, Larimar Therapeutics' Times Interest Earned (Quarter) stood at -$107.99 in 2016, then crashed by 1446.21% to -$1669.8 in 2017, then soared by 98.24% to -$29.44 in 2018, then surged by 31.68% to -$20.11 in 2019, then skyrocketed by 41.15% to -$11.84 in 2020.
  • Its Times Interest Earned was -$11.84 in Q1 2020, compared to -$20.11 in Q4 2019 and -$30.3 in Q3 2019.